Retatrutide, the newest type of weight-loss drug, helped people lose an average of 70 pounds or about 30% of their body weight over 80 weeks, according to study data from the drugs manufacturer
GLP-1 medications may be preferred over other weight loss drugs due to their non-stimulant nature, reducing the risk of side effects related to stimulant medications
High riskcharacterized by two or more clinical thresholds, suicidal ideation, or substantial psychological distressrequires prompt referral to a qualified mental-health professional
Diabetic complications | Treatment summaries | BNF NICE
With drug prices ranging from $200 to $1,500 per month and 82% of people experiencing plan restrictions, selecting the correct insurance is essential
Ro has since played a key role in bringing new Zepbound treatment delivery options to market faster while ensuring patients can access them at the lowest available cash pay price